Sir,
We read with interest the recent article by Eilertson et al., 1 'CG258 Klebsiella pneumoniae isolates without b-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City', wherein the authors conduct an investigation of K. pneumoniae causing bloodstream infection in New York City in 1999, 2003-04, 2006, 2009 and 2013 . However, we felt that readers would benefit from further discussion of the results in the context of what is known about clonal group (CG) 258, in particular from recent genomic analyses.
In the article by Eilertson et al., 1 CG258 was defined in the discussion section as 'ST258 and its single allele variants', referring to alleles of the seven-locus MLST scheme. 2 Notably, this definition includes ST11, which: (i) has been shown to be the ancestor of ST258; (ii) differs from ST258 by a single allele (tonB); and (iii) is explicitly included in the definition of CG258 in numerous other studies. [2] [3] [4] [5] Genomic analyses by six independent groups have concluded that ST258 evolved from an ST11 ancestor 3-8 into which an 1 Mbp sequence was imported from an ST442 strain.
3, 6 The imported region includes the capsule locus harbouring wzi154 3,6-8 (referred to as cps-2 in Eilertson et al.,
1 now designated KL107 under the standardized nomenclature 9 ) and the tonB-79 allele, which replaced the tonB-4 allele of ST11, converting it into ST258.
3 Notably, in the article by Eilertson et al. 1 the PCR used to screen for CG258 isolates targets the tonB-79 allele of ST258, which is not present in ST11.
Hence, the screen detects only the tonB-79 subgroup of CG258 and is specifically unable to detect ST11 isolates, which may be the most informative members of CG258 in terms of their potential to reveal details of the early emergence of ST258.
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Eilertson et al.
1 report that the earliest ST258 isolates they identified (2003) carried wzi154, while some later isolates carried wzi29 and occasionally other wzi alleles. This is as expected given the previously reported genomic data, which show that following the initial formation of ST258-wzi154 (KL107), a subsequent 50 kbp recombination event occurred with an ST42 K. pneumoniae, 3,4,6-8 importing a new capsule locus harbouring wzi29 to form the ST258-wzi29 subclade (referred to as cps-1 in Eilertson et al.,
1 designated KL106 under the standardized nomenclature 9 ). The genomic comparisons therefore support a line of descent from ST11 to ST258-wzi154 to ST258-wzi29 (summarized in Figure 1 ). Molecular dating analyses estimate that ST258 emerged from ST11 in the mid-1990s 4,5 and the ST258-wzi29 subclade emerged 7-8 years later in the early 2000s. 4 The detection of ST258-wzi154 (KL107) in 2003, with ST258-wzi29 (KL106) detected later, is therefore consistent with the prior data on the stepwise evolution of ST258. However, contrary to the statements in the manuscript of Eilertson et al., 1 these data do not suggest that KL107 (wzi154) was the initial capsule type of CG258, either in New York City or globally, as the study captured only ST258 and its direct derivatives that form just one subgroup of CG258 (as discussed above). The ancestral capsule type of the entire CG, or of the ST11 progenitor strain from which ST258 emerged through recombination, remains unknown because CG258 harbours extensive capsule locus diversity (e.g. see Figure 1 ).
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Transparency declarations
None to declare. 1 correctly state that the PCR assay used to define CG258 only targets the tonB-79 subgroup; however, this oversight is somewhat mitigated by the lack of ST11 isolates from our hospitals over the period studied. Thus, the findings of our recent study 2 are representative of regions such as Brooklyn, New York, where ST11 isolates are rare.
Based on the noted lack of ST11 isolates we cannot comment on the ancestral capsule type in those isolates. Further study on historical ST11 K. pneumoniae isolates is needed to fill this knowledge gap.
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